Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines

Leukemia and Lymphoma

Volumn 43, Issue 12, 2002, Pages 2409-2411

  Athanasiadou, A ^a   Saloum, R ^a   Zorbas, I ^a   Tsompanakou, A ^a   Batsis, I ^a   Fassas, A ^a   Anagnostopoulos, A ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

Acute promyelocytic leukemia; Anthracyclines; Monosomy 5 and 7; Therapy related myelodysplastic syndrome

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BETA 2 MICROGLOBULIN; CD3 ANTIGEN; CYTARABINE; DAUNORUBICIN; DNA FRAGMENT; GYRASE INHIBITOR; HLA ANTIGEN; IDARUBICIN; INTERFERON; INTERLEUKIN 2; MERCAPTOPURINE; MESSENGER RNA; METHOTREXATE; RETINOIC ACID; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME ANALYSIS; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPING; LEUKEMOGENESIS; MONOSOMY; MONOSOMY 5; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CHROMOSOME 5; CHROMOSOME 7; FATALITY; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; SECOND CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036891498     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000040143     Document Type: Article

References (12)

1. Zompi, S. and Viguie, F. (2002) "Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia", Leuk. Lymphoma 43, 275-278.
2. Bseiso, R., Kantarjian, H. and Estay, E. (1997) "Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia", Leukemia 11, 168-169.
3. Zompi, S., Legrand, O., Bouscary, D., Blanc, C.M., Picard, F., Casadevall, N., Dreyfus, F., Marie, J.P. and Viguie, F. (2000) "Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): a report of two cases and a review of the literature", Br. J. Haematol. 110, 610-613.
4. Bennett, J., Catovsky, D., Daniel, M., Flandrin, G., Galton, D., Gralnick, H. and Sultan, C. (1985) "Proposed revised criteria for the classification of acute myeloid leukaemia: a report of the French-American-British cooperative group", Ann. Intern. Med. 103, 620-625.
5. Grimwade, D., Howe, K., Langabeer, S., Davies, L., Oliver, F., Walker, H., Swirsky, D., Wheatley, K., Goldstone, A., Burnett, A. and Solomon, E. (1996) "Establishing the presence of the t (15; 17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into M.R.C. ATRA trial", Br. J. Haematol. 94, 557-573.
6. Pedersen-Bjergaard, J. and Philip, P. (1991) "Two different classes of therapy-related and de-novo acute myeloid leukemia?", Cancer Genet. Cytogenet. 55, 119-124.
7. Pedersen-Bjergaard, J. and Rowley, J. (1994) "The balanced and unbalanced chomosome abberration of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation", Blood 83, 2780-2786.
8. Pedersen-Bjergaard, J., Pedersen, M., Roulston, D. and Philip, P. (1995) "Different genetic pathways in leukemogenesis to patient presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia", Blood 86, 3542-3552.
9. Karp, J. and Sarkodee-Adoo, C. (2000) "Therapy-related acute leukemia", Clin. Lab. Med. 20, 71-81.
10. Secker Walker, L., Moorman, A., Bain, B. and Metha, A. (1998) "Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop", Leukemia 12, 840-844.
11. Heim, S. and Mitelman, F. (1995) Cancer Cytogenetics, 2nd Ed. (Wiley-Liss, New York), pp. 109-110.
12. Harris, N.L., Jaffe, E., Deibold, J., Flandrin, G., Konrad Muller-Hermelink, K., Virdiman, J., Lister, A. and Bloomfield, C. (1999) "World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997", J. Clin. Oncol. 17, 3835-3849.